1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 29 SEPTEMBER 2014

CNS Drug News 29 SEPTEMBER 2014

  • October 2014
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Companion Diagnostics Could See New Alzheimer's Drugs Succeed
Industry Brief - MedGenesis/Pfizer Enter Agreement For Potential PD Treatments
Industry Trend Analysis - AstraZeneca/Lilly Deal Shares Risk Over Potential Blockbuster Alzheimer's Drug
Industry Trend Analysis - Litigation Threatens Namenda Switch Plan
Industry Brief - TauRx Achieves Enrolment Target For Second Phase III Trial Of LMTX In AD
Industry Brief - Aricept Phase III Trial In Chinese Patients With Severe AD Meets Primary Endpoint
Industry Brief - Evotec And Partners Awarded Public Grants To Develop New MS Drug Candidates
Industry Trend Analysis - Eisai Extends Aricept's Lifecycle With Japanese Approval For DLB
Industry Trend Analysis - SDP Targets Growing Cell Therapy Market With SB623 Deal
Industry Brief - NovaDel Sells ZolpiMist NDA/Licence/Intellectual Property To Amherst
Industry Brief - Lundbeck Commences European Launch Of Brintellix In Denmark
Industry Trend Analysis - Abilify Successor On Course For FDA Approval In 2015
Industry Brief - Shire Reaches Final Agreement With US Government
Industry Brief - FDA Approves Abilify Maintena Dual-Chamber Syringe
Industry Brief - PAION Grants Licence To Yichang For M6G In China
Industry Brief - Galen To Sell Penthrox In UK/Ireland
Industry Brief - Actavis Confirms Generic Butrans Patent Challenge
Industry Brief - KemPharm Receives US Patent For Novel Prodrug Of Hydromorphone
Industry Brief - Trevena Granted Key US Composition Of Matter Patent For TRV130
Industry Brief - Lannett Launches Oxycodone Oral Solution In US
Industry Brief - Milestone Triggered As Selincro Enters Market In France
Industry Trend Analysis - Novo Nordisk To Invest In Obesity Research With New Unit
Industry Brief - Edison Announces EPI-743 Phase II Results In Rett Syndrome
Industry Brief - Acorda To Acquire Civitas Therapeutics
Industry Brief - SiteOne Completes Financing Round/Secures NIH Grant
Industry Brief - Avraham Raises Funds For Ongoing Ladostigil Phase IIb Trial

Table Of Contents

CNS Drug News 29 SEPTEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • December 2016
  • by Transparency Market Research

Europe Neurological Disorder Drugs Market: Overview This report on the neurological disorder drugs market studies the current as well as future prospects of the market in Europe. Health concern related ...

Epiomic Epidemiology Series: Lewy Body Dementia Forecast in 12 Major Markets 2017-2027

Epiomic Epidemiology Series: Lewy Body Dementia Forecast in 12 Major Markets 2017-2027

  • $ 5112
  • Industry report
  • February 2017
  • by Black Swan Analysis Ltd

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Lewy Body Dementia in 12 Major Markets Dementia with Lewy Bodies (DLB) is the second most frequent cause of age related neurodegenerative ...

Epiomic Epidemiology Series: Alzheimer%s Disease Forecast in 12 Major Markets 2017-2027

Epiomic Epidemiology Series: Alzheimer%s Disease Forecast in 12 Major Markets 2017-2027

  • $ 5112
  • Industry report
  • February 2017
  • by Black Swan Analysis Ltd

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Alzheimer’s disease in 12 Major Markets Alzheimer's disease (AD) is a progressive, irreversible neurodegenerative disorder. It is ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.